BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1347@pharmaconomics
DTSTAMP:20260707T041005Z
DTSTART;VALUE=DATE:20260101
DTEND;VALUE=DATE:20260102
SUMMARY:AZN Phase 2 — Saphnelo
DESCRIPTION:Phase 2 trial results for Saphnelo in systemic lupus erythematosus are due Jan 1\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/901832/000165495426003936/a9587b.htm\n\nTrack it: https://www.pharmaconomics.com/e/1347
URL:https://www.pharmaconomics.com/e/1347
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:AZN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR